Medtronic has launched the Cardioblate BP2 Surgical Ablation System, which offers cardiac surgeons new ease and flexibility in creating ablation lines during open heart procedures. The Medtronic Cardioblate BP2 system consists of the Cardioblate BP2 device, a Cardioblate pen and generator. The Cardioblate BP2 device incorporates dual linear electrodes delivering bipolar irrigated radiofrequency energy to heart tissue at the touch of a trigger. Saline irrigation facilitates energy flow, allowing swift, deep heating that quickly neutralizes cells in a linear fashion. The low profile, slim, flexible neck and rotating head of the Cardioblate BP2 device eases access to all necessary areas of the heart. The two 7cm, malleable electrodes can be individually shaped by the surgeon to conform to the heart's contours for precise tissue contact.
The new Cardioblate BP2 system builds on the medical acceptance of advanced technologies represented in three predecessor radiofrequency devices, the Medtronic Cardioblate Bipolar System, the Monopolar Cardioblate Pen and XL pen and the new DETECT mapping tool. The Cardioblate system is the world's first surgical ablation system able to create all necessary lesions of the Maze III procedure without additional equipment.
|
